|
|
Exchange: |
N/A |
Security
Type: |
Common |
Shares
Out: |
53,710,000 |
Market
Cap: |
1.13(B) |
Last
Volume: |
0 |
Avg
Vol: |
0 |
52
Week Range: |
$19.68 - $76.43 |
|
Level
I Sector: |
N/A |
Level
II Sector: |
N/A |
Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile Prothena is a clinical-stage neuroscience company. Co. is developing a pipeline of therapeutic candidates for a number of indications and targets. Co.'s partnered programs include prasinezumab (PRX002/RG7935) for the potential treatment of Parkinson's disease and other related synucleinopathies, and programs that target tau, TDP-43 and an undisclosed target for the potential treatment of Alzheimer's disease, amyotrophic lateral sclerosis, frontotemporal dementia or other neurodegenerative diseases. Co.'s proprietary programs include PRX004 for the potential treatment of ATTR amyloidosis, and programs that target Amyloid beta for the potential treatment of Alzheimer's disease.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
0 |
10,000 |
127,333 |
880,407 |
Total Sell Value |
$0 |
$355,952 |
$7,418,948 |
$47,344,812 |
Total People Sold |
0 |
1 |
7 |
12 |
Total Sell Transactions |
0 |
2 |
28 |
85 |
End Date |
2024-03-10 |
2023-12-08 |
2023-06-09 |
2022-06-09 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Collier Richard T |
Director |
|
2022-04-05 |
4 |
OE |
$6.41 |
$32,050 |
D/D |
5,000 |
6,219 |
|
- |
|
Ecor1 Capital, Llc |
10% Owner |
|
2022-01-12 |
4 |
B |
$37.50 |
$11,250,300 |
I/I |
300,000 |
11,584,280 |
1.5 |
-29% |
|
Selkoe Dennis J. |
Director |
|
2022-01-03 |
4 |
AS |
$46.81 |
$237,233 |
D/D |
(5,000) |
2,845 |
|
-50% |
|
Selkoe Dennis J. |
Director |
|
2022-01-03 |
4 |
OE |
$9.23 |
$46,150 |
D/D |
5,000 |
7,845 |
|
- |
|
Walker Karin L |
Chief Accounting Officer |
|
2021-11-23 |
4 |
AS |
$57.51 |
$261,573 |
D/D |
(4,519) |
0 |
|
-25% |
|
Walker Karin L |
Chief Accounting Officer |
|
2021-11-23 |
4 |
OE |
$15.04 |
$67,966 |
D/D |
4,519 |
4,519 |
|
- |
|
Malecek Michael J |
See Remarks |
|
2021-11-19 |
4 |
AS |
$55.00 |
$550,000 |
D/D |
(10,000) |
0 |
|
-32% |
|
Malecek Michael J |
See Remarks |
|
2021-11-19 |
4 |
OE |
$10.27 |
$102,700 |
D/D |
10,000 |
10,000 |
|
- |
|
Karp Carol D. |
Chief Regulatory Officer |
|
2021-11-01 |
4 |
AS |
$55.00 |
$571,818 |
D/D |
(10,000) |
0 |
|
-42% |
|
Karp Carol D. |
Chief Regulatory Officer |
|
2021-11-01 |
4 |
OE |
$15.04 |
$150,400 |
D/D |
10,000 |
10,000 |
|
- |
|
Malecek Michael J |
See Remarks |
|
2021-10-27 |
4 |
AS |
$58.07 |
$585,250 |
D/D |
(10,000) |
0 |
|
-38% |
|
Malecek Michael J |
See Remarks |
|
2021-10-27 |
4 |
OE |
$10.27 |
$102,700 |
D/D |
10,000 |
10,000 |
|
- |
|
Walker Karin L |
Chief Accounting Officer |
|
2021-10-20 |
4 |
AS |
$60.00 |
$1,385,823 |
D/D |
(23,000) |
0 |
|
-46% |
|
Walker Karin L |
Chief Accounting Officer |
|
2021-10-20 |
4 |
OE |
$15.04 |
$390,230 |
D/D |
23,000 |
23,000 |
|
- |
|
Karp Carol D. |
Chief Regulatory Officer |
|
2021-10-01 |
4 |
AS |
$66.60 |
$682,336 |
D/D |
(10,000) |
0 |
|
-50% |
|
Karp Carol D. |
Chief Regulatory Officer |
|
2021-10-01 |
4 |
OE |
$15.04 |
$150,400 |
D/D |
10,000 |
10,000 |
|
- |
|
Selkoe Dennis J. |
|
|
2021-10-01 |
4 |
AS |
$66.35 |
$339,176 |
D/D |
(5,000) |
2,845 |
|
-50% |
|
Selkoe Dennis J. |
|
|
2021-10-01 |
4 |
OE |
$9.23 |
$46,150 |
D/D |
5,000 |
7,845 |
|
- |
|
Karp Carol D. |
Chief Regulatory Officer |
|
2021-09-09 |
4 |
AS |
$71.45 |
$719,847 |
D/D |
(10,000) |
0 |
|
-51% |
|
Karp Carol D. |
Chief Regulatory Officer |
|
2021-09-09 |
4 |
OE |
$15.04 |
$150,400 |
D/D |
10,000 |
10,000 |
|
- |
|
Selkoe Dennis J. |
|
|
2021-07-30 |
4 |
AS |
$48.99 |
$247,374 |
D/D |
(5,000) |
2,845 |
|
-1% |
|
Selkoe Dennis J. |
|
|
2021-07-30 |
4 |
OE |
$9.23 |
$71,315 |
D/D |
5,000 |
7,845 |
|
- |
|
Henney Christopher S |
Director |
|
2021-07-14 |
4 |
AS |
$55.31 |
$616,020 |
D/D |
(11,108) |
0 |
|
2% |
|
Henney Christopher S |
Director |
|
2021-07-14 |
4 |
OE |
$11.33 |
$125,854 |
D/D |
11,108 |
11,108 |
|
- |
|
Henney Christopher S |
|
|
2021-07-12 |
4/A |
AS |
$53.84 |
$1,326,128 |
D/D |
(23,892) |
0 |
|
- |
|
350 Records found
|
|
Page 8 of 14 |
|
|